In order to compare the efficiency of Nutlin-3-dependent p53 stabilisation with that of known DNA-damaging agents, we treated human colorectal cancer cells (HCT116p53+/+) with Etoposide (100 μM) or Nutlin-3 (10 μM). Here, TP53 is linked to colorectal cancer.